Lead Product(s) : Cilostazol
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : SK Chemicals
Deal Size : Inapplicable
Deal Type : Inapplicable
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
Details : Cilostazol is a Other Small Molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Diabetes Mellitus, Type 2.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 25, 2025
Lead Product(s) : Cilostazol
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : SK Chemicals
Deal Size : Inapplicable
Deal Type : Inapplicable